# Study of ZGGS34 in Participants With Advanced Solid Tumors

> **NCT07258121** · PHASE1,PHASE2 · RECRUITING · sponsor: **Suzhou Zelgen Biopharmaceuticals Co.,Ltd** · enrollment: 400 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **BIOLOGICAL:** ZG006

## Key facts

- **NCT ID:** NCT07258121
- **Lead sponsor:** Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-31
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07258121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07258121, "Study of ZGGS34 in Participants With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07258121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*